Dyadic International Set to Announce Q3 Financial Results
JUPITER, Fla. — Dyadic International, Inc., also known as Dyadic Applied BioSolutions, is gearing up to report its financial results for the third quarter of 2025. This announcement is scheduled for Wednesday, November 12, 2025. As an innovative global biotechnology company, Dyadic focuses on the scalable production of functional input proteins that are essential in various sectors including life sciences, food, nutrition, and industrial applications.
Understanding Dyadic’s Conference Call Details
Accompanying the financial results announcement, Dyadic will hold a corporate update conference call. This is a significant opportunity for interested parties to gain insights into the company's latest developments. The details for the conference call are as follows:
Date and Time
The conference call will take place on November 12, 2025, at 5:00 p.m. Eastern Time. This timing ensures participants can join easily from various time zones.
Dial-In Information
Participants can join the call by using the following numbers: Toll-Free: +1-877-407-0784 and International: +1-201-689-8560. It’s advisable to dial in a few minutes early to ensure connectivity.
Webcast Access
For those who prefer an online format, a webcast will also be available. An archive of this webcast will be accessible within 24 hours after the event. This can be found in the Investor Relations section of the Dyadic website, which ensures that stakeholders can stay informed even if they miss the live call.
What to Expect from Dyadic’s Financial Updates
Dyadic Applied BioSolutions has positioned itself as a leader in biotechnology, contributing significantly to how proteins are produced and utilized in various industries. The upcoming financial report is expected to shed light on the company’s performance and strategic direction. Investors and analysts will be keen to hear about growth metrics and future projections during this update.
Engaging with Management
To facilitate an interactive experience, Dyadic encourages stakeholders to submit questions for management beforehand. Any queries can be sent via email prior to the conference call. This is a fantastic opportunity for participants to engage directly with the leadership team.
About Dyadic Applied BioSolutions
Dyadic Applied BioSolutions utilizes proprietary microbial platforms to manufacture recombinant proteins. These proteins are then sold or licensed to partners, enhancing efficiencies in the food, nutrition, and bio-industrial sectors. The company’s innovative C1 and Dapibus™ expression systems are pivotal in ensuring cost-effective and flexible manufacturing processes. This approach underpins Dyadic's expanding portfolio of commercial programs, further solidifying its position in the competitive biotechnology landscape.
Frequently Asked Questions
When will Dyadic International report its Q3 2025 financial results?
Dyadic will announce its Q3 financial results on November 12, 2025.
What time is the corporate update conference call scheduled?
The corporate update call is set for 5:00 p.m. Eastern Time on the same day.
How can investors participate in the conference call?
Investors can join via toll-free or international dial-in numbers provided by the company, or through an online webcast.
Will a recording of the conference call be available?
Yes, a webcast archive will be available within 24 hours on the Investor Relations section of the Dyadic website.
What is Dyadic’s primary business focus?
Dyadic focuses on the scalable production of functional input proteins for use in various industries including life sciences and food and nutrition.
